SHANK3 Gene Polymorphism Rs2146772569: A Replication in Iraqi Middle Euphrates Children
Keywords:
Autism, Polymorphism, IraqAbstract
Autism spectrum disorder is a neurodevelopmental condition marked by persistentchallenges in social communication and interaction, along with limited and repetitive behavior,
hobbies, or activities. Neuroimaging and examinations have shown disturbances in the structure
and functioning of the brain, namely in regions responsible for social communication and sensory
processing. Multiple genes contribute to synapse function and plasticity. Shank3 is an example of
a gene that has been linked to a higher risk to autism. It functions by controlling the organization
and activity of synapses, which are vital for neuronal transmission. Several genetic variations in
the shank3 gene have been extensively investigated. Numerous single nucleotide polymorphisms
(SNPs) have been identified and found to have a deleterious impact on the function of this protein.
This study examined the shank3 SNP (Rs2146772569) in Iraqi population. A total of forty healthy
children and thirty children diagnosed with Autism Spectrum disease (ASD) have been selected to
participate in this study. The aim of the study is to examine the relationship between shank3 SNP
and autism spectrum disease in the Iraqi community. Genomic DNA was isolated from blood
samples, followed by PCR amplification and subsequent preparation of the samples for
sequencing.The statistical analysis was conducted using the SPSS software tool. The findings
indicate that the frequency of the C—T allele (CC, CT, and TT genotypes) are 37.5%, 32.5%, and
30% in healthy persons, and 26.67%, 23.33%, and 50% in patients. The frequency of C→T
mutations are 53.75% and 46.25% in healthy persons, and 38.33% and 61.67% in autistic children,
respectively. The findings indicate that there is no notable correlation between this specific single
nucleotide polymorphism (SNP) and autistic spectrum disorder in children from Iraq
References
H. R. Park et al., “A Short Review on the Current Understanding of Autism Spectrum
Disorders,” Exp Neurobiol, vol. 25, no. 1, pp. 1–13, Feb. 2016, doi: 10.5607/en.2016.25.1.1.
“https://www.cdc.gov/ncbddd/autism/data.html.”
“https://www.mdpi.com/2076-3425/10/5/274.”
H. O. Salhia, L. A. Al-Nasser, L. S. Taher, A. M. Al-Khathaami, and A. A. El-Metwally,
“Systemic review of the epidemiology of autism in Arab Gulf countries.,” Neurosciences
(Riyadh), vol. 19, no. 4, pp. 291–6, Oct. 2014.
B. Tick, P. Bolton, F. Happé, M. Rutter, and F. Rijsdijk, “Heritability of autism spectrum
disorders: a meta‐analysis of twin studies,” Journal of Child Psychology and Psychiatry, vol. 57,
no. 5, pp. 585–595, May 2016, doi: 10.1111/jcpp.12499.
R. E. Rosenberg, J. K. Law, G. Yenokyan, J. McGready, W. E. Kaufmann, and P. A. Law,
“Characteristics and Concordance of Autism Spectrum Disorders Among 277 Twin Pairs,” Arch
Pediatr Adolesc Med, vol. 163, no. 10, p. 907, Oct. 2009, doi: 10.1001/archpediatrics.2009.98.
A. M. Grabrucker, “Environmental factors in autism.,” Front Psychiatry, vol. 3, p. 118,
, doi: 10.3389/fpsyt.2012.00118.
P. Monteiro and G. Feng, “SHANK proteins: roles at the synapse and in autism spectrum
disorder,” Nat Rev Neurosci, vol. 18, no. 3, pp. 147–157, Mar. 2017, doi: 10.1038/nrn.2016.183.
A. Mossa, F. Giona, J. Pagano, C. Sala, and C. Verpelli, “SHANK genes in autism:
Defining therapeutic targets,” Prog Neuropsychopharmacol Biol Psychiatry, vol. 84, pp. 416–423,
Jun. 2018, doi: 10.1016/j.pnpbp.2017.11.019.
“https://www.sciencedaily.com/releases/2019/03/190307131356.htm.”
C. M. Durand et al., “SHANK3 mutations identified in autism lead to modification of
dendritic spine morphology via an actin-dependent mechanism,” Mol Psychiatry, vol. 17, no. 1,
pp. 71–84, Jan. 2012, doi: 10.1038/mp.2011.57.
D. Woike et al., “Mutations affecting the N-terminal domains of SHANK3 point to
different pathomechanisms in neurodevelopmental disorders,” Sci Rep, vol. 12, no. 1, p. 902, Jan.
, doi: 10.1038/s41598-021-04723-5.
S. M. H. Mubarak, D. A. F. Al-Koofee, H. F. S. Al-Zubaidy, S. B. Mohammed, and Z. F.
Al-Zubaidy, “PIRA-PCR technique is a resolve for any unavailable restriction enzyme of single
nucleotide polymorphism,” Ann Trop Med Public Health, vol. 23, no. 18, 2020, doi:
36295/ASRO.2020.231832
Downloads
Published
Issue
Section
License
Copyright (c) 2024 University of Thi-Qar Journal Of Medicine
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.